Admission plasma glucose levels within the normal to mildly impaired range and the outcome of patients with acute coronary syndrome

Abstract

Background:

Elevated admission plasma glucose levels >140 mg/dl are associated with adverse clinical outcomes in both diabetic and non-diabetic patients admitted with acute coronary syndrome (ACS). We aimed to evaluate the association between admission plasma glucose levels <140 mg/dl and the outcome of non-diabetic patients admitted with acute coronary syndrome.

Methods:

The study population consisted of patients with acute coronary syndrome included in the Acute Coronary Syndrome Israeli Survey during 2000–2013. Diabetic patients were excluded. The primary endpoint was all-cause mortality at one year.

Results:

The 4520 patients had a mean age of 61.7±13.5 years and were stratified into four quartiles according to admission plasma glucose (60–94, 95–105, 106–119, 120–140 mg/dl). Patients with higher admission plasma glucose were older and included a higher percentage of smokers. In addition, the higher the glucose so also did they have a poorer risk factor profile including a higher body mass index, total and low-density lipoprotein cholesterol and triglyceride levels, and lower high-density lipoprotein cholesterol levels. During the first year 5.2% of patients died. A comparison of one-year mortality according to admission plasma glucose quartiles demonstrated a significant and progressive increase in mortality risk as admission plasma glucose rose (3.5%, 4.1%, 6.1%, 6.4%, respectively, p=0.001). However, this association lost its clinical significance following a multivariate analysis (p=0.08).

Conclusions:

High admission plasma glucose levels within the normal to mildly impaired range are associated with increased one-year mortality in non-diabetic acute coronary syndrome patients. However, the higher glucose level is probably not the cause for the adverse outcome but rather a marker for high risk. Our findings support the definition of 140 mg/dl as the cutoff for clinically acceptable admission glucose levels in patients with acute coronary syndrome.

Keywords

Glucose acute coronary syndrome mortality

Get full access to this article

View all access options for this article.

References

Savonitto

Morici

Cavallini

et al . One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: Effect of diabetic status and admission hyperglycemia. J Am Geriatr Soc 2014; 62: 1297–1303.

Deckers

van Domburg

et al . Relation of admission glucose levels, short- and long-term (20-year) mortality after acute myocardial infarction. Am J Cardiol 2013; 112: 1306–1310.

Djordjevic-Radojkovic

Koracevic

Stanojevic

et al . Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodeling. Acute Card Care 2013; 15: 38–43.

Capes

Hunt

Malmberg

et al . Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773–778.

Squire

Nelson

et al . Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: Results from 4702 index cases in routine practice. Clin Sci (Lond) 2010; 118: 527–535.

Gholap

Mehta

et al . Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study. BMJ Open 2012; 2: e001596.

Otten

Ottervanger

Timmer

et al . Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: A cohort study. Diabetol Metab Syndr 2013; 5: 34.

Yosefy

. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: Has it been resolved? Acta Diabetol 2003; 40: S380–S388.

Yang

Laubach

French

et al . Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 2009; 137: 723–729.

10.

Akalin

Temiz

Akcar

et al . Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes. Endocr J 2008; 55: 861–866.

11.

Zarich

Nesto

. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 2007; 115: e436–e439.

12.

Timmer

Ottervanger

et al . Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM 2006; 99: 237–243.

13.

Karabulut

Iltumur

Toprak

et al . Insulin response to oral glucose loading and coronary artery disease in nondiabetics. Int Heart J 2005; 46: 761–770.

14.

Geisler

Mueller

Aichele

et al . Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: Prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions. Clin Res Cardiol 2010; 99: 743–752.

15.

Hartge

Unger

Kintscher

. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 2007; 4: 84–88.